Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06641713
What this trial is testing

HAIC Compared With TACE in Huge Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatic ChemotherapyLiver Cancer
Sun Yat-sen University 664
Not applicableStudy completedNCT03318380
What this trial is testing

Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 612
Not applicableNot Yet RecruitingNCT07704203
What this trial is testing

Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy

Who this might be right for
Hepatic CancerHepatocellular CarcinomaIntrahepatic Cholangiocellular Carcinoma+1 more
Second Affiliated Hospital of Xi'an Jiaotong University 150
Testing effectiveness (Phase 2)Study completedNCT01752920
What this trial is testing

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Who this might be right for
Solid Tumor
Basilea Pharmaceutica 119
Early research (Phase 1)Study completedNCT01171924
What this trial is testing

A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors

Who this might be right for
Head and Neck CancerLiver CancerBreast Cancer+2 more
Curis, Inc. 47
Testing effectiveness (Phase 2)UnknownNCT02133079
What this trial is testing

Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96

Who this might be right for
Liver CancerPancreatic Adenocarcinoma
Cure&Sure Biotech Co., LTD 20
Testing effectiveness (Phase 2)UnknownNCT04523662
What this trial is testing

Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 27
Not applicableWithdrawnNCT06144827
What this trial is testing

A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer

Who this might be right for
Cancer, HepatocellularRadiotherapy Side Effect
Montefiore Medical Center
Not applicableActive Not RecruitingNCT04242342
What this trial is testing

Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors

Who this might be right for
Radiotherapy
Centre Georges Francois Leclerc 46
Testing effectiveness (Phase 2)Ended earlyNCT05797870
What this trial is testing

Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Center Eugene Marquis 16
Large-scale testing (Phase 3)Study completedNCT03412773
What this trial is testing

Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
BeiGene 684
Not applicableUnknownNCT05996666
What this trial is testing

Primary Liver Cancer Early Detection

Who this might be right for
Liver Cancer
The First Hospital of Jilin University 701
Not applicableNot Yet RecruitingNCT05750329
What this trial is testing

Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)

Who this might be right for
Liver Transplant DisorderHepatic CancerEnd-stage Liver Disease
RenJi Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01126645
What this trial is testing

Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
University of Magdeburg 529
Testing effectiveness (Phase 2)Study completedNCT01375569
What this trial is testing

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerCarcinoma, Hepatocellular
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Ended earlyNCT02721056
What this trial is testing

NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers

Who this might be right for
Liver Cancer
Nanobiotix 23
Early research (Phase 1)Study completedNCT00976170
What this trial is testing

Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Hepatocellular Carcinoma
Chugai Pharmaceutical 42
Not applicableLooking for participantsNCT07295275
What this trial is testing

Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

Who this might be right for
Liver Cancer
West China Hospital 200
Not applicableNot Yet RecruitingNCT06715072
What this trial is testing

Study on the Efficacy and Safety of Transarterial Chemoembolization Combined With Targeted Immunotherapy in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Liver Cancer
Yao Xie 70
Early research (Phase 1)Active Not RecruitingNCT02932956
What this trial is testing

Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)

Who this might be right for
Liver Cancer
Baylor College of Medicine 10
Next Page